UCI Health Chao Family Comprehensive Cancer Center

What UCI Health Chao Family Comprehensive Cancer Center does

UCI Health Chao Family Comprehensive Cancer Center (CFCCC) is the only National Cancer Institute (NCI)-designated comprehensive cancer center in Orange County, California, and one of 53 in the United States. Operated as part of the University of California, Irvine, the center delivers multidisciplinary cancer care across the full continuum — prevention, screening, treatment, and survivorship — while running an extensive translational research portfolio spanning basic, clinical, and population science. The center is organized into disease-oriented teams supported by shared research resources, drawing investigators from 32+ UCI departments across seven schools; the center itself employs 39 staff in this role. Recent capability additions include an in-house AI Cancer Detection and Treatment System and ARPA-H-funded next-generation lymphatic imaging technology, reflecting a deliberate push toward AI-augmented diagnostics and treatment planning.

CFCCC operates a hybrid academic medical center revenue model with four distinct streams: (1) clinical services billed through UCI Health, with new capacity added via the UCI Medical Center Irvine-Newport expansion in 2025; (2) extramural research funding, which reached $106 million in fiscal 2022-23, a 28% year-over-year increase; (3) philanthropic giving, anchored by cumulative gifts exceeding $50 million from the Chao and Stern families including a $20 million Chao family gift around 2021; and (4) institutional support from the University of California system. Strategic partnerships — including the Caris Life Sciences Precision Oncology Alliance and an NCI-funded cancer health equity collaboration with Cal State Fullerton — extend the center's data assets, community reach, and commercial monetization pathways beyond the institutional footprint. The center's go-to-market is fundamentally referral-driven and reputation-driven rather than sales-driven, leveraging the NCI designation as the primary demand-generation asset in a catchment of approximately 3.2 million residents.

Name

UCI Health Chao Family Comprehensive Cancer Center

Legal name

UC Irvine Chao Family Comprehensive Cancer Center

Website

https://cancer.uci.edu

Company type

Private

Founded year

1994

Operating status

Operating

Headcount range

11–50 employees

Short description

UCI Health Chao Family Comprehensive Cancer Center is the sole NCI-designated comprehensive cancer center in Orange County, delivering multidisciplinary oncology care, translational research, and AI-augmented diagnostics across UC Irvine's seven schools and 32+ departments.

Ownership category

akta.pro rank

Product category

Oncology and academic cancer care services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Voluntary Health Organizations (813212)

SIC

Services-Hospitals (8060), Services-Health Services (8000)

akta.pro primary industry

Hospital-Integrated Cancer Centers (Acute Oncology Programs) (HLAFAAAM)

akta.pro secondary industries

Academic Medical Centers (AMCs) & Teaching Hospitals (HLAFAAAA), Academic Medical Centers & Teaching Hospitals (University-Affiliated) (EDAHAGAA), Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS) (BPAGACAA)

Keywords

• Cancer treatment services
• Clinical cancer research
• Oncology clinical trials
• Cancer patient care
• Translational cancer research

Headquarters

HQ city

Orange

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Others

Revenue model

1. Clinical Care Services: Revenue from providing cancer treatment, diagnostics, and clinical services to patients through UCI Health system.
2. Research Grants and Funding: Federal and state research grants including NCI P30 Cancer Center Support Grant, CIRM funding ($4.6 million for next-generation immune-cell therapies), and various NIH awards. CFCCC received $106 million for basic, translational and clinical studies in fiscal 2022-23.
3. Philanthropy and Donations: Director's Circle annual giving program ($500-$5,000+ levels), major gifts ($20M from Chao family, $2M from Nicholas R. Conway and Betty Sha Family), Anti-Cancer Challenge community fundraising (100% directed to pilot studies and clinical trials).

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

The UC Irvine Chao Family Comprehensive Cancer Center is an NCI-designated comprehensive cancer center delivering multidisciplinary cancer care, research, and clinical trials across Orange County. It operates three themed research programs supported by seven shared resources and disease-oriented teams, runs early-phase and investigator-initiated clinical trials through the Stern Center, and provides comprehensive patient care including prevention, diagnosis, treatment, and survivorship. The center also conducts community outreach (e.g., OC3, CHERP), runs training for high-school through faculty-level learners, and operates fundraising vehicles such as the Anti-Cancer Challenge and Director's Circle giving society.

Product overview

The UCI Chao Family Comprehensive Cancer Center is an NCI-designated comprehensive cancer center (the only one in Orange County) offering an integrated portfolio of cancer research, clinical care, and community programs. The center operates through three themed research programs (Biotechnology Imaging & Drug Development, Systems Pathways & Targets, Cancer Control) supported by seven shared resources and disease-oriented teams. Clinical services include early-phase trials through the Stern Center and comprehensive patient care across Orange County. The center also conducts community outreach via OC3 and CHERP, offers education programs from high school through faculty levels, and runs fundraising initiatives including the Anti-Cancer Challenge and Director's Circle giving society. A major expansion is underway with the UCI Medical Center in Irvine.

Differentiator

Problem solved

Functional benefit

Brands

• The Allen and Lee-Hwa Chao Lectureship in Cancer Research: An annual lecture series established in 1999 to provide a forum for discussing and sharing cutting-edge advancements in cancer research, prevention and treatment. Hosts world-renowned leaders who deliver both a technical colloquium and a public lecture.
• Director's Circle – Annual Giving Society
• UCI Anti-Cancer Challenge

Products and services

• Patient Care Services Comprehensive multidisciplinary cancer care including clinical specialties, patient support services, and patient resources delivered through UCI Health cancer centers in Orange County and (from 2025) the new UCI Medical Center in Irvine.
• Clinical Trials and Clinical Research Early-phase and investigator-initiated clinical trials conducted through the Stern Center for Cancer Clinical Trials and Research, offering patients access to promising research-driven trials and therapies.
• Cancer Research Programs Interdisciplinary research programs including Biotechnology Imaging & Drug Development, Systems Pathways & Targets, and Cancer Control, organized into three themed research programs with disease-oriented teams linking discoveries to clinical applications.
• Director's Circle Annual Giving Society Annual giving program with membership levels (Friend of the Director $500–$999; Director's Circle Member $1,000–$2,499; Silver Circle $2,500–$4,999; Gold Circle $5,000+) supporting innovative research and leading-edge cancer clinical trials.
• Anti-Cancer Challenge Community movement to raise awareness and funds for cancer research where 100% of participant fundraising goes directly to promising pilot studies and early-phase clinical trials conducted by cancer center physician-scientists.
• Education and Training Programs Education and training programs for high school students, graduate students (including the Oncology Summer Internship), faculty, and undergraduate students, including trainee membership and travel awards.
• Community Outreach and Engagement Community programs including the Office of Community Outreach & Engagement, the Orange County Cancer Coalition (OC3), and the CSUF/UCI-CFCCC Cancer Health Equity Research Partnership (CHERP) addressing cancer health disparities in Orange County.
• Allen and Lee-Hwa Chao Lectureship in Cancer Research Annual lecture series (established 1999) bringing world-renowned cancer researchers to deliver both technical and public lectures on cutting-edge advancements in cancer research, prevention, and treatment.

Quantifiable outcome

• Only NCI-designated comprehensive cancer center in Orange County serving sixth-most populated U.S. county
• +2 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature2 records

Partnerships

Six partnerships are on record, tiered core.

• Caris Life Sciences (Precision Oncology Alliance)coreStrategic or Co-development Partner · 31 January 2023UCI Health Chao Family Comprehensive Cancer Center joined the Caris Precision Oncology Alliance, a network of leading cancer centers collaborating to advance precision oncology and molecular profiling.
• California State University, Fullerton (CSUF)coreStrategic or Co-development Partner · 26 January 2022NCI-funded partnership ($1.1+ million grant) focused on addressing cancer disparities in Orange County. Partnership includes CSUF/UCI-CFCCC Cancer Health Equity Research Partnership (CHERP).
• UCI School of MedicinecoreStrategic or Co-development PartnerParent institution providing medical education, clinical training, and research infrastructure. Seven schools at UCI collaborate through CFCCC.
• UCI HealthcoreStrategic or Co-development PartnerParent health system providing clinical care delivery, hospital facilities, and patient access network.
• Chao Family Comprehensive Cancer Center at UCI Medical Center IrvinecoreStrategic or Co-development PartnerExpansion of CFCCC services to new UCI Medical Center in Irvine through $20 million single biggest donation from long-time benefactor.
• Allen and Lee-Hwa Chao Lectureship SpeakerscoreStrategic or Co-development PartnerAnnual lectureship bringing world-renowned cancer researchers including Jennifer Wargo (MD Anderson), George Q. Daley (Harvard), John D. Carpten (City of Hope), Karen Winkfield (Vanderbilt-Meharry).

Scale indicators5 records

Recent moves7 records

Expansion highlights4 records

Broad incumbents

• MD Anderson Cancer Center: The largest NCI-designated comprehensive cancer center in the US, with the deepest trial portfolio and global brand - an aspirational incumbent peer for research output and trial enrollment benchmarks.
• Memorial Sloan Kettering Cancer Center: National leader among NCI-designated comprehensive cancer centers, operating at vastly larger scale across research, trials, and clinical care - sets the bar CFCCC benchmarks itself against.

Direct peers

• UCSF Helen Diller Family Comprehensive Cancer Center: UC system's leading NCI-designated comprehensive cancer center with deep basic/translational research programs, shared resources, and catchment-area population science - a benchmark UC-affiliated peer.
• Huntsman Cancer Institute: NCI-designated comprehensive cancer center at the University of Utah with a comparable catchment-area-focused research model, shared resources, and early-phase trials program.
• City of Hope Comprehensive Cancer Center: NCI-designated comprehensive cancer center in Southern California (Duarte) operating an integrated research-clinical model closely paralleling CFCCC's structure, including disease teams, shared resources, and early-phase trials.
• USC Norris Comprehensive Cancer Center: USC-affiliated NCI-designated comprehensive cancer center providing cancer research, clinical trials, and multidisciplinary care - a direct academic comparator in the same Southern California geography.
• Cedars-Sinai Samuel Oschin Cancer Center: Large Los Angeles-based academic cancer program with a comprehensive portfolio of clinical trials, precision oncology, and multidisciplinary care - a major Southern California competitor for patients, faculty, and trials.
• Stanford Cancer Institute: NCI-designated comprehensive cancer center at Stanford, integrating schools of Medicine, Engineering and Basic Sciences - structurally analogous to CFCCC's 32+ department, 7-school integration model.
• UC San Diego Moores Cancer Center: UC system's other NCI-designated comprehensive cancer center, operating an academic cancer center model across UC schools with disease-oriented teams and translational research programs.
• UCLA Jonsson Comprehensive Cancer Center: UCLA's NCI-designated comprehensive cancer center with a similar academic-medical-center structure, multidisciplinary research programs, and a major early-phase trials portfolio in the Los Angeles market.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/cancer-chao-family-comprehensive-center

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles16 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about UCI Health Chao Family Comprehensive Cancer Center